1832 Asset Management L.P. Axogen, Inc. Transaction History

1832 Asset Management L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$34.05 - $55.9 $11.8 Million - $19.4 Million	-347,400 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$36.15 - $52.5 $10.8 Million - $15.8 Million	300,000 Added 632.91%	347,400 $17 Million
Q1 2018 May 15, 2018	BUY	$24.4 - $40.25 $1.16 Million - $1.91 Million	47,400 New	47,400 $1.74 Million

176

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $749M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on 1832 Asset Management L.P. with notifications on news.